Ele Biotech

At, we work to ensure that neurodegenerative diseases associated with dementia can be detected before it’s too late. is to bring into real-world clinical practice by developing molecular diagnostic kits based on qPCR. We are committed to a biotechnology that is precise, accessible, and scalable, designed to integrate into population screening programs, primary care, and personalized healthcare: → We research with rigor, transparency, and responsibility, always prioritizing evidence. → We foster an inclusive environment, with women at the forefront and real opportunities for all- → We develop technology with empathy, focused on the well-being of patients, families, and communities. → We challenge the status quo with solid science and a bold vision for change. → We make coherent, ethical, and sustainable decisions, always putting social impact first. → We apply the highest scientific, regulatory, and quality standards at every stage of the project. ELE Biotech is a deep tech company founded and led by Laura Vallés Saiz (PhD) and Elena Calvo Cantero, two women with complementary backgrounds in science and innovation. Born in Spain with a global outlook, ELE Biotech is working to transform the future of dementia diagnostics. If you share our purpose and want to be part of this journey — let’s connect.